Target intelligence / Profile preview

Norovirus GI.1 major capsid protein (VP1)

Target
VP1
Molecular classification
Viral structural protein, Major capsid protein, Other
01

Overview

Norovirus GI.1 major capsid protein (VP1) is the principal structural protein forming the icosahedral capsid of norovirus, which causes a significant proportion of human acute viral gastroenteritis cases worldwide[1][2][4][5][7]. VP1 is encoded by ORF2 and forms 90 stable dimers, totaling 180 monomers per virion, with each monomer comprising distinct domains: a conserved shell (S) domain and a highly variable protruding (P) domain, further divided into P1 and P2 subdomains[1][2][5][7]. The P domain mediates binding to host cellular receptors, namely histo-blood group antigens (HBGA), which are essential for virus entry and tropism[6][7]. VP1 presents key epitopes for neutralizing antibodies, making it a focus of vaccine and antiviral therapeutic development[5][6]. High conformational flexibility of the P domain contributes to immune evasion and adaptability, presenting challenges for vaccine efficacy but also opportunities for inhibition by nanobodies and small molecule HBGA mimics[3][5][6].

Other names
Norwalk virus capsid proteinViral protein 1VP1HuNoV VP1Norovirus major capsid protein
02

Mechanism of action

Blockade of virus binding to histo-blood group antigens (HBGA)[6] Capsid destabilization or aggregation via antibody binding[6]

03

Biological functions

Structural component of viral capsidVirus-host cell attachmentImmune evasionAntigen for neutralizing antibodiesOther
04

Disease associations

InfectionGastroenteritis
05

Safety considerations

High variability/antigenic drift creates challenges for broad-spectrum antivirals and vaccines[5][6]Viral escape from neutralizing antibodies[5]
06

Interacting drugs

2-fucosyllactose (2'FL) (inhibits binding to host HBGAs)[6]

2 more in the full profile.

07

Biomarkers

Presence of VP1 in stool (diagnostic marker)[6]Antibody titers against VP1 (serological marker)[5]

Beyond the preview

Go deeper on Norovirus GI.1 major capsid protein (VP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norovirus GI.1 major capsid protein (VP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call